Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Breakup of Pfizer and Allergan shaped the year

Smaller deals filled the void left by a megamerger that wasn’t to be

by Ann M. Thayer
December 5, 2016 | A version of this story appeared in Volume 94, Issue 48

Article:

This article has been sent to the following recipient: